Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Serostim $704 Mil. Settlement Is Largest For Off-Label Marketing Case

Executive Summary

Serono's $704 mil. settlement over Serostim promotional practices marks the largest penalty ever paid by a pharmaceutical manufacturer to resolve civil and criminal investigations into off-label marketing

You may also be interested in...



When Is On-Label Speech Off-Label Promotion? Par Links The Two In Suit Against FDA

Par Pharmaceutical Inc.’s First Amendment suit against FDA offers a new approach to battling government allegations of off-label marketing.

When Is On-Label Speech Off-Label Promotion? Par Links The Two In Suit Against FDA

Par Pharmaceutical Inc.’s First Amendment suit against FDA offers a new approach to battling government allegations of off-label marketing.

Merck Serono Settlement On Rebif Kickbacks Expands, Extends Existing Integrity Agreement With OIG

The company agrees to pay $44.3 million under a deal with the Department of Justice and tack three years onto a corporate integrity agreement in effect since 2005.

Related Content

Topics

UsernamePublicRestriction

Register

PS046479

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel